Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France.

Guelfucci F, Clay E, Aballéa S, Lassalle R, Moore N, Toumi M

Open source

DOI
10.1186/1472-6823-13-15
Published
2013 Apr 29
Container
BMC endocrine disorders
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/1472-6823-13-15,
  title = {Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France.},
  author = {Guelfucci F and Clay E and Aballéa S and Lassalle R and Moore N and Toumi M},
  year = {2013},
  journal = {BMC endocrine disorders},
  doi = {10.1186/1472-6823-13-15},
  url = {https://doi.org/10.1186/1472-6823-13-15}
}

RIS

TY  - JOUR
TI  - Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France.
AU  - Guelfucci F
AU  - Clay E
AU  - Aballéa S
AU  - Lassalle R
AU  - Moore N
AU  - Toumi M
PY  - 2013
JO  - BMC endocrine disorders
DO  - 10.1186/1472-6823-13-15
UR  - https://doi.org/10.1186/1472-6823-13-15
ER  - 

APA

F, G., E, C., S, A., R, L., N, M., & M, T. (2013). Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France.. BMC endocrine disorders. https://doi.org/10.1186/1472-6823-13-15

Source records